HoyaMEX:7741N 93 Net Margin % is 21.44% as of Mar. 2026, which is 5% below its 10-year median of 22.65. GuruFocus rates MEX:7741N with a GF Score™ of 93/100 and a GF Value™ of MXN2,048.30 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Hoya ranks better than 93.15% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Hoya's Net Income for the
three
months ended in Mar. 2026 was MXN6,161 Mil. Hoya's Revenue for the
three
months ended in Mar. 2026 was MXN28,732 Mil. Therefore, Hoya's net margin for the quarter that ended in Mar. 2026 was 21.44%.
The historical rank and industry rank for Hoya's Net Margin % or its related term are showing as below:
MEX:7741N'
s Net Margin % Range Over the Past 10 Years
Min: 17.71 Med: 22.65 Max: 25.41
Current: 25.41
MEX:7741N's Net Margin % is ranked better than 93.15% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs MEX:7741N: 25.41
Hoya (MEX:7741N) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Hoya Net Margin % Related Terms
Hoya Net Margin % Historical Data
* Premium members only.
The historical data trend for Hoya's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:7741N vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Hoya's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoya Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hoya's Net Margin % distribution charts can be found below:
* The bar in red indicates where Hoya's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hoya (MEX:7741N) has a Net Margin % of 21.44% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Hoya and its competitors. This is near median its historical median of 22.65. Over the past decade, Hoya's Net Margin % has ranged from 17.71 to 25.41. According to the industry distribution chart, Hoya ranks #56 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 6.9%.
Is Hoya's Net Margin % too high?
Hoya's current Net Margin % of 21.44% is near median its 10-year median of 22.65. Over the past 10 years, this metric has ranged from a low of 17.71 to a high of 25.41. The Medical Devices & Instruments industry median Net Margin % is 2.07. Hoya's value of 21.44% is 935.7% above this industry median. Based on the distribution chart, Hoya ranks #56 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hoya has a GF Score™ of 93/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoya's Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hoya ranks #56 out of 817 companies for Net Margin %. This places Hoya in the top 7% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Hoya's value of 21.44% is 935.7% above this benchmark. Historically, Hoya's own Net Margin % has ranged from 17.71 to 25.41 over the past decade. While the company's 10-year median is 22.65 vs. the industry median of 2.07, Hoya has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoya's current Net Margin % of 21.44% is 935.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Hoya and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoya's current Net Margin % is 21.44%, which is near median its own 10-year median of 22.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoya stock overvalued right now?
Based on GuruFocus' analysis, Hoya (MEX:7741N) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN2,048.30, compared to a current price of MXN2,750.59 — trading 34.3% above its estimated fair value. The current Net Margin % is 21.44%, which is near median its 10-year median of 22.65 and 935.7% above the Medical Devices & Instruments industry median of 2.07. Hoya's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Hoya (MEX:7741N), the current Net Margin % is 21.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoya (MEX:7741N) Overvalued in 2026?
Based on GuruFocus' analysis, Hoya stock appears to be overvalued.
The current stock price of MXN2,750.59 is trading 34.3% above its estimated GF Value™ of MXN2,048.30.
GuruFocus considers Hoya to be Significantly Overvalued.
Key valuation signals for MEX:7741N:
Net Margin %: 21.44% (near median its 10-year median of 22.65)
GF Value™: MXN2,048.30 vs. price of MXN2,750.59 (34.3% above fair value)
Industry Position: 935.7% above the Medical Devices & Instruments median (#56 of 817)
No single metric tells the full story. See the MEX:7741N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 1941 in Tokyo as an optical glass production plant, Hoya is one of the largest eyeglass lens manufacturers in the world. Leveraging its technology know-how in glass manufacturing, Hoya entered the mask blanks business in 1974. Now although its life care business accounts for more than 60% of its total revenue, majority of its profit before tax comes from its higher-margin IT business.
93GF Score
Get the complete analysis for MEX:7741N
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:7741N has been successfully added to your 
